References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
In the UK, formula feeding has traditionally been recommended for all mothers with HIV to eliminate any risk of passing the virus through breastmilk. However, guidance is evolving. Some UK clinics now support informed breastfeeding for women on effective ART with a sustained undetectable viral load, provided strict monitoring is in place.
If you want to breastfeed, the most important step is to discuss it openly with your HIV team. Never breastfeed without their knowledge and support.
Order a discreet home HIV test
The UK Position
BHIVA (British HIV Association) updated its guidance to acknowledge that the risk of transmission through breastfeeding is very low when the mother is on effective ART with an undetectable viral load. However, the risk is not zero. The guidance supports an informed choice approach with close monitoring.
Conditions for Safer Breastfeeding
| Condition | Why It Matters |
|---|---|
| Sustained undetectable viral load | Reduces transmission risk to very low levels |
| Full adherence to ART | Any missed doses can allow viral load to rise |
| Regular viral load monitoring | Monthly during breastfeeding |
| Baby receiving ART prophylaxis | Added protection during breastfeeding period |
| No breast problems | Mastitis, cracked nipples and bleeding increase risk |
| Close clinical supervision | Both mother and baby monitored throughout |
When to Stop Breastfeeding Immediately
- If your viral load becomes detectable
- If you develop mastitis, cracked or bleeding nipples
- If you miss ART doses
- If your baby develops oral thrush or mouth sores
- If you become unwell
Have a supply of formula at home so you can switch immediately if needed.
Monitoring During Breastfeeding
- Maternal viral load checked monthly
- Baby tested for HIV during and after breastfeeding
- Regular clinic appointments for both mother and baby
- Open communication with your HIV team about any problems
Mixed Feeding
Mixed feeding (combining breast and formula) was historically thought to increase risk because formula can irritate the gut lining, but recent evidence suggests the risk difference is small when viral load is undetectable. Your HIV team will advise based on the latest evidence.
Making Your Decision
The choice between breast and formula feeding is personal. Neither option makes you a better or worse parent. What matters is that your baby is fed, healthy and loved. If breastfeeding is important to you culturally or personally, talk to your HIV team — they can help you do it as safely as possible.
Read more: Getting pregnant with HIV | Pregnancy and birth with HIV | What is HIV?
Frequently Asked Questions
Is it safe to breastfeed with HIV in the UK?
With an undetectable viral load, full ART adherence and close monitoring, the risk is very low but not zero. UK clinics increasingly support informed breastfeeding under strict conditions.
Will my baby need HIV medication while I breastfeed?
Usually yes. Your baby will likely receive antiretroviral prophylaxis during the breastfeeding period as an extra precaution.
How long can I breastfeed?
This depends on your clinical situation and your HIV team’s advice. The shorter the breastfeeding period, the lower the cumulative risk. Many clinics recommend stopping by 6 months.
Related reading
- Can Condoms Protect Against HIV?
- Why Is an HIV Prevention Vaccine So Difficult to Develop?
- Do You Have to Disclose Your HIV Status to an Employer?
- Disclosing Your HIV Status: Who, When and How
- Do Condoms Prevent STIs?
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
